Apex Trader Funding — Intraday Trail / Standard 150K

Intraday Trail 150K / Standard: USD 1190.00 reference one-time evaluation fee, 30 calendar days of access and USD 4000 maximum trailing loss allowance. Simulated PA payouts require qualifying days, consistency and a safety net; maximum six payouts.

PROGRAM AT A GLANCE

Costs, rules & payouts

Verified · 2026-11-20 01:52 UTC

Evaluation and funded-stage terms can differ. Read the conditions below. Unknown values do not mean zero or unlimited.

Availability: Listed in the official Apex plan picker.

Account options: Current 30-day evaluation (one-time fee, no rebill, no resets). Safety net USD 154,100; minimum balance to request USD 154,600.

Account size
US$ 150,000
Initial / one-time fee
US$ 1,190
Monthly fee
US$ 0
Profit target
US$ 9,000
Maximum drawdown
Evaluation and PA: USD 4,000.

Costs & evaluation

Account size (USD)
US$ 150,000
Evaluation type
Intraday Trail / Standard — current 30-day evaluation
Initial fee (USD)
US$ 1,190
Recurring monthly fee (USD)
US$ 0

Targets & risk limits

Profit target (USD)
US$ 9,000
Maximum drawdown (USD)
Evaluation and PA: USD 4,000.
Drawdown calculation
Intraday trailing, enforced in real time; stops trailing at the drawdown amount + USD 100.
Daily loss limit
Evaluation: none. PA: daily loss limit applies (shown as YES in the official picker).
Minimum trading days
Evaluation: can pass in one day; 30-day access. PA must be activated within 7 days of passing.
Maximum contracts
Evaluation: 12 minis / 120 micros. PA: up to 10 minis / 100 micros with scaling.
Consistency rules
Evaluation: none. PA: 50%.

Payout conditions

Payout frequency
PA: 5 trading days with USD 300+ profit per cycle.
Minimum withdrawal
US$ 500
Payout cap
PA payouts 1–6: USD 2,500, 3,000, 3,000, 4,000, 4,000, 5,000. Maximum 6 payouts per PA.
Sim-funded payout buffer (USD)
4100
Profit split
100% of approved payouts.

Trading & eligibility

News trading restrictions
Not verified
Overnight holding
Not verified
Supported platforms
Not verified
Country eligibility
Not verified
Simulated/live pathway
Not verified

Sources & review

Official evidence
Official source ↗
Field-level research sources

Partial criteria review. Unlisted fields have not been checked in this review. Confirm current terms before purchase; conflicts and add-ons remain noted in the fields.

CriterionCheckedOfficial evidence
Profit target (USD)2026-11-14Source 1 ↗

Research notes & original sources

This catalog entry identifies an account option documented by the linked official source. It is a partial review, not a complete statement of trading or payout rules. Blank fields are unknown.

Prices, where listed, are source snapshots before optional add-ons and promotions. Confirm the exact purchase terms before paying.

Choose whether external media can load. Optional content is off by default.

No analytics or advertising tracking is configured by this consent module. Read our Privacy Policy.